Business

Exclusive distribution agreement with MAXCARE Inc

Exclusive distribution agreement with MAXCARE Inc.

articleOptibiotix Health PlcMay 11, 20203/company/optibiotix-health-plc/news/exclusive-distribution-agreement-with-maxcare-inc
Exclusive distribution agreement with MAXCARE Inc

About this update from Optibiotix Health Plc

[{"type":"text","content":"\n \n \n RNS Number : 3368M\n OptiBiotix Health PLC\n 11 May 2020\n  \n \n \n OptiBiotix Health plc\n \n \n (\n \n \"OptiBiotix\" or the \"Company\")\n \n  \n Exclusive distribution agreement with MAXCARE Inc. for SlimBiome® in Taiwan\n  \n \n OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high\n \n \n cholesterol, diabetes and skincare,announces it has entered into a distribution agreement for SlimBiome® with MAXCARE Inc (\"MAXCARE\"). The agreement grants MAXCARE exclusive rights to commercialise OptiBiotix's SlimBiome® proprietary weight management technology in Taiwan.\n \n  \n \n \n MAXCARE (\n https://www.maxcarecorp.com\n ) is a Taiwanese company based in Taipei founded in 2000 which specialises in clinically-supported, science based nutraceuticals, fruit and botanical extracts. MAXCARE's ingredients span a wide range of application areas with an existing distribution network and experience in commercialising weight management ingredients.  Market exclusivity is linked to minimum sales targets being achieved.\n \n \n  \n \n \n MAXCARE is one of Taiwan's leading distributors for nutraceutical raw materials which offers a complete portfolio of products, technological development support and logistical services. Their distribution channels include TV shopping, chain pharmacies, drug stores and direct/multi-layer selling. They are well placed to educate customers on the benefits and functionality SlimBiome® can provide and have a team of registered dieticians to support commercialisation. \n \n  \n \n \n This is another strategic step by OptiBiotix to commercilise its award-winning SlimBiome® technology into new markets. The commercial aim is to develop SlimBiome® as an innovative ingredient that can be added to multiple products in different application areas incorporating science backed functionality and additional value to everyday products.\n \n  \n \n \n Thomas O'Hara, Business Development Manager at Optibiotix\n \n , commented: \n \n \"We are pleased to have signed an agreement with MAXCARE to commercialise our award-winning weight management technology in Taiwan.  We chose MAXCARE due to their experience in commercialising weight mana...

More updates from Optibiotix Health Plc